Literature DB >> 21451936

Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis?

Pinaki Dutta1, Anil Bhansali, Kim Vaiphei, Usha Dutta, P Ravi Kumar, Shariq Masoodi, Kanchan Kumar Mukherjee, Alka Varma, R Kochhar.   

Abstract

Patients with acromegaly have higher prevalence of colorectal neoplasms. The pathogenetic mechanism is still unclear and may be related to sustained increase in serum GH-IGF1. We aimed to evaluate the proliferative and apoptotic markers in samples of colonic mucosa obtained during screening colonoscopic biopsy from patients with acromegaly and study their relationship to serum IGF-1 and GH levels. The study subjects included 32 patients with acromegaly (4 female), 10 healthy controls (irritable bowel syndrome) and 10 positive controls (non-acromegalic colonic adenocarcinoma). Patients with acromegaly were divided into two groups, active disease (AD) and disease in remission (AR). Two biopsies each were obtained during colonoscopy from the right colon, transverse colon and rectosigmoid region. All the polyps were biopsied and subjected to histopathological examination. Immunohistochemistry for proliferation marker (Ki-67) and apoptotic markers (caspase-3 and TdT-Mediated dUTP Nick-End Labeling (TUNEL) was carried out in the histopathological samples. Indices of proliferation were significantly different in patients with acromegaly as compared to healthy controls. The mean Ki-67 positivity was 45.1 ± 17.7% in AD and 45.6 ± 23.1% in AR, as compared to 10 ± 5% in healthy controls. While none of the healthy controls had Ki-67 positivity beyond the lower third of crypts, among patients with acromegaly 12/32 (37.5%) had mid-third positivity (P = 0.000) and 15/32 (46.8%) had full length of crypt positively (P = 0.00). Immunostaining for caspase-3 was negative in patients with acromegaly and healthy controls. TUNEL was strongly positive in patients with colonic adenocarcinoma but not in healthy controls and patients with acromegaly. IGF-1 levels were higher in those with Ki-67 positivity in the superficial mucosa. Patients with acromegaly have increased proliferation of colonic epithelial cells. Elevated levels of serum IGF1 are associated with increase proliferation in the superficial crypt cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21451936     DOI: 10.1007/s11102-011-0300-9

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  35 in total

Review 1.  Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy.

Authors:  James D Lewis; Kimmie Ng; Kenneth E Hung; Warren B Bilker; Jesse A Berlin; Colleen Brensinger; Anil K Rustgi
Journal:  Arch Intern Med       Date:  2003-02-24

Review 2.  The death-associated protein kinases: structure, function, and beyond.

Authors:  Shani Bialik; Adi Kimchi
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly.

Authors:  P J Jenkins; V Frajese; A M Jones; C Camacho-Hubner; D G Lowe; P D Fairclough; S L Chew; A B Grossman; J P Monson; G M Besser
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

4.  Colorectal neoplasm and acromegaly.

Authors:  Anil Bhansali; Pinaki Dutta; Mohammad Hayat Bhat; S K Sinha; R Kochar; K Vaiphi
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 5.  Acromegaly pathogenesis and treatment.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2009-11-02       Impact factor: 14.808

6.  Changes in the expression of suppressor of cytokine signalling (SOCS) 2 in the colonic mucosa of acromegalic patients are associated with hyperplastic polyps.

Authors:  Fausto Bogazzi; Federica Ultimieri; Francesco Raggi; Dania Russo; Aurelio Costa; Emanuele Marciano; Luigi Bartalena; Enio Martino
Journal:  Clin Endocrinol (Oxf)       Date:  2008-09-24       Impact factor: 3.478

7.  The prevalence of polyp in colon of patients with acromegaly.

Authors:  Bagher Larijani; Rasool Aliannejad; Nasibeh Khaleghnejad-Tabari; Reza Baradar-Jalili; Reza Ansari; Seyed-Mohammad Tavangar; Fatemeh Bandarian
Journal:  Arch Iran Med       Date:  2007-04       Impact factor: 1.354

8.  Increased epithelial cell proliferation in the colon of patients with acromegaly.

Authors:  A Cats; R P Dullaart; J H Kleibeuker; F Kuipers; W J Sluiter; M J Hardonk; E G de Vries
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

9.  Prevalence of colonic polyps is not increased in patients with acromegaly: analysis of 60 patients from India.

Authors:  Anil Bhansali; Rakesh Kochhar; Yogesh K Chawla; Somashekara Reddy; Radharaman Jiban Dash
Journal:  J Gastroenterol Hepatol       Date:  2004-03       Impact factor: 4.029

Review 10.  Cell death in health and disease.

Authors:  Richard A Lockshin; Zahra Zakeri
Journal:  J Cell Mol Med       Date:  2007-11-20       Impact factor: 5.310

View more
  10 in total

Review 1.  Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.

Authors:  Sripriya Raman; Adda Grimberg; Steven G Waguespack; Bradley S Miller; Charles A Sklar; Lillian R Meacham; Briana C Patterson
Journal:  J Clin Endocrinol Metab       Date:  2015-04-03       Impact factor: 5.958

Review 2.  Complications of acromegaly: thyroid and colon.

Authors:  Amit Tirosh; Ilan Shimon
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 3.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

4.  Predictors of colonic pathologies in active acromegaly: single tertiary center experience.

Authors:  Raim Iliaz; Sema Ciftci Dogansen; Seher Tanrikulu; Gulsah Yenidunya Yalin; Bilger Cavus; Mine Gulluoglu; Filiz Akyuz; Sema Yarman
Journal:  Wien Klin Wochenschr       Date:  2018-07-30       Impact factor: 1.704

5.  Increased thyroid cancer risk in acromegaly.

Authors:  Selcuk Dagdelen; Nese Cinar; Tomris Erbas
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

Review 6.  Acromegaly: clinical features at diagnosis.

Authors:  Lucio Vilar; Clarice Freitas Vilar; Ruy Lyra; Raissa Lyra; Luciana A Naves
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

7.  The prevalence and associated factors of colorectal neoplasms in acromegaly: a single center based study.

Authors:  Masaaki Yamamoto; Hidenori Fukuoka; Genzo Iguchi; Ryusaku Matsumoto; Michiko Takahashi; Hitoshi Nishizawa; Kentaro Suda; Hironori Bando; Yutaka Takahashi
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

8.  Clinical manifestations and diagnosis of acromegaly.

Authors:  Gloria Lugo; Lara Pena; Fernando Cordido
Journal:  Int J Endocrinol       Date:  2012-02-01       Impact factor: 3.257

9.  Experimental study of nasopharyngeal carcinoma radionuclide imaging and therapy using transferred human sodium/iodide symporter gene.

Authors:  Xing Zhong; Changzheng Shi; Jian Gong; Bin Guo; Mingzhu Li; Hao Xu
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

10.  Synchronous esthesioneuroblastoma and growth-hormone-secreting pituitary macroadenoma: combined open and endoscopic management.

Authors:  Costanza J Valdes; Marc A Tewfik; Marie-Christine Guiot; Salvatore Di Maio
Journal:  J Neurol Surg Rep       Date:  2014-07-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.